Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  PAREXEL International Corporation    PRXL   US6994621075

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. is a biopharmaceutical services company, which provides clinical research, clinical logistics, medical communications, consulting, commercialization and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

The company operates its business through three segments: Clinical Research Services, PAREXEL Consulting & Medical Communication Services and Perceptive Informatics.

The Clinical Research Services segment includes services such as clinical trials management and biostatistics, data management, clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacovigilance, and investigator site services.

The PAREXEL Consulting & Medical Communication Services segment provides a spectrum of market development, product development and targeted communications services in support of product launch.

The Perceptive Informatics segment provides information technology solutions designed to improve client's product development processes.

The segments portfolio of products and services includes ClinPhone RTSM, IMPACT CTMS, DataLabs EDC, web-based portals, systems integration, electronic patient reported outcomes and LIQUENT InSight Regulatory Information Management platform.PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1982 and is headquartered in Waltham, MA.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,03964.2%1,30465.3% +20.32%
Perceptive190.6811.8%228.3511.4% +16.5%
Paraxel Consulting and Medical Communications Services167.1310.3%202.5210.1% +17.48%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
The Americas635.2939.3%867.0043.4% +26.73%
Europe, Middle East & Africa555.4734.3%624.0131.3% +10.98%
Asia/Pacific205.7512.7%243.4312.2% +15.48%
Surperformance© rating of PAREXEL International Corp
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Advertisement
Sector Biotechnology
Trading RatingInvestor Rating
GILEAD SCIENCES, ..
AMGEN, INC.
BIOGEN IDEC INC
CELGENE CORPORATI..
CSL LIMITED
Sector Biotechnology
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451-1111

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF